Skip to content

Lucid Diagnostics LUCD Interest coverage

Interest coverage at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
-164×-197×
Guardant Health logo
Guardant HealthGH
-100.5×-28.6×
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-3.1×-0.7×
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-1,358×
Personalis, Inc. logo
Personalis, Inc.PSNL
-457.7×-188×
GeneDx Holdings logo
GeneDx HoldingsWGS
-147.7×+0.3×

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Calculated from Lucid Diagnostics’s reported figures.

Based on trailing twelve months.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's interest coverage?
Lucid Diagnostics (LUCD) reported interest coverage of -2,463.4× in Q1 2026.
How has Lucid Diagnostics's interest coverage changed year-over-year?
Lucid Diagnostics's interest coverage decreased by 18.7% year-over-year, from -2,076× to -2,463.4×.
What is the long-term trend for Lucid Diagnostics's interest coverage?
Over 4 years (2021 to 2025), Lucid Diagnostics's interest coverage has grown at a 168.4% compound annual growth rate (CAGR), from -41.6× to -2,158.3×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.